Analysis of F8 inversions as risk factors for FVIII inhibitor development in Indian severe haemophilia A patients

被引:4
作者
Pinto, Patricia [1 ]
Ghosh, Kanjaksha [1 ]
Shetty, Shrimati [1 ]
机构
[1] ICMR, Natl Inst Immunohaematol, Mumbai 400012, Maharashtra, India
关键词
FVIII inhibitors; F8; inversions; Haemophilia A; India; FACTOR-VIII INHIBITORS; GENE;
D O I
10.1016/j.bcmd.2014.04.007
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
FVIII inhibitor development in haemophilia A (HA) patients, especially those with severe manifestations is a serious adverse effect in patients with haemophilia A, and the clinical management of these patients is very difficult as most don't respond to conventional treatment. Many genetic and non-genetic risk factors have been proposed however, these are diverse in different population groups, highlighting the importance of determining specific risk factors for each population. F8 mutations and especially inversions, which are the most common causative mutation in severe HA, have been significantly associated with inhibitor development earlier, however there is no conclusive data so far with regard to Indian haemophiliacs. This study provides novel evidence that intron 22 inversions in the F8 gene are indeed significantly associated with FVIII inhibitor development in Indian haemophiliacs. Further studies with other risk factors would enable better insights into the immune response towards FVIII in these patients, and possibly help to characterize patients at a higher risk for inhibitor development. (C) 2014 Elsevier Inc. All rights reserved.
引用
收藏
页码:161 / 163
页数:3
相关论文
共 40 条
  • [31] A prevalent CTLA4 missense variant significantly associates with inhibitor development in Argentine patients with severe haemophilia A
    Marchione, V. D.
    Zuccoli, J. R.
    Abelleyro, M. M.
    Radic, C. P.
    Neme, D.
    Candela, M.
    de Tezanos Pinto, M.
    De Brasi, C. D.
    Rossetti, L. C.
    HAEMOPHILIA, 2017, 23 (02) : E166 - E169
  • [32] F8 gene mutation spectrum in severe hemophilia A with inhibitors: A large cohort data analysis from a single center in China
    Sun, Jie
    Li, Zekun
    Huang, Kun
    Ai, Di
    Li, Gang
    Xie, Xingjuan
    Gu, Hao
    Liu, Guoqing
    Zhen, Yingzi
    Chen, Zhenping
    Wu, Runhui
    RESEARCH AND PRACTICE IN THROMBOSIS AND HAEMOSTASIS, 2022, 6 (04)
  • [33] Influence of class I and II HLA alleles on inhibitor development in severe haemophilia A patients from the South of Brazil
    De Barros, M. F.
    Herrero, J. C. M.
    Sell, A. M.
    De Melo, F. C.
    Braga, M. A.
    Pelissari, C. B.
    Machado, J.
    De Souza Schiller, S.
    De Souza Hirle, L.
    Visentainer, J. E. L.
    HAEMOPHILIA, 2012, 18 (03) : e236 - e240
  • [34] A possible mechanism for Inv22-related F8 large deletions in severe hemophilia A patients with high responding factor VIII inhibitors
    Fujita, J.
    Miyawaki, Y.
    Suzuki, A.
    Maki, A.
    Okuyama, E.
    Murata, M.
    Takagi, A.
    Murate, T.
    Suzuki, N.
    Matsushita, T.
    Saito, H.
    Kojima, T.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2012, 10 (10) : 2099 - 2107
  • [35] Inhibitor development in previously untreated patients with severe haemophilia: A comparison of included patients and outcomes between a clinical study and a registry-based study
    Jonker, Carla J.
    Oude Rengerink, Katrien
    Hoes, Arno W.
    Mol, Peter G. M.
    van den Berg, H. Marijke
    HAEMOPHILIA, 2020, 26 (05) : 809 - 816
  • [36] The Distribution of Lifestyle Risk Factors Among Patients with Stroke in the Indian Setting: Systematic Review and Meta-Analysis
    Varkey, Biji P.
    Joseph, Jaison
    Varghese, Abin
    Sharma, Suresh K.
    Mathews, Elezebeth
    Dhandapani, Manju
    Narasimha, Venkata Lakshmi
    Kuttan, Radha
    Shah, Saleena
    Dabla, Surekha
    Dhandapani, Sivashanmugam
    ANNALS OF NEUROSCIENCES, 2023, 30 (01) : 40 - 53
  • [37] Systematic review and meta-analysis of comorbidities and associated risk factors in Indian patients of community-acquired pneumonia
    Ghia, Canna Jagdish
    Rambhad, Gautam Sudhakar
    SAGE OPEN MEDICINE, 2022, 10
  • [38] Ethnicity-specific impact of HLA I/II genotypes on the risk of inhibitor development: data from Korean patients with severe hemophilia A
    Kim, Hyun-Young
    Cho, Jin-Hee
    Kim, Hee-Jung
    Chung, Hae-Sun
    Kim, Sun-Hee
    Lee, Ki-O
    Jung, Soo-Young
    Yoo, Ki-Young
    Kim, Hee-Jin
    ANNALS OF HEMATOLOGY, 2018, 97 (09) : 1695 - 1700
  • [39] Treatment-related risk factors for inhibitor development in non-severe hemophilia A after 50 cumulative exposure days: A case-control study
    Abdi, Amal
    Eckhardt, Corien L.
    van Velzen, Alice S.
    Vuong, Caroline
    Coppens, Michiel
    Castaman, Giancarlo
    Hart, Dan P.
    Hermans, Cedric
    Laros-van Gorkom, Britta
    Leebeek, Frank W. G.
    Mancuso, Maria Elisa
    Mazzucconi, Maria G.
    McRae, Simon
    Oldenburg, Johannes
    Male, Christoph
    van der Bom, Johanna G.
    Fijnvandraat, Karin
    Gouw, Samantha C.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2021, 19 (09) : 2171 - 2181
  • [40] Analysis of risk factors for myelodysplasias, leukemias and death from infection among patients with congenital neutropenia.: Experience of the French Severe Chronic Neutropenia Study Group
    Donadieu, J
    Leblanc, T
    Meunier, BB
    Barkaoui, M
    Fenneteau, O
    Bertrand, Y
    Maier-Redelsperger, M
    Micheau, M
    Stephan, JL
    Phillipe, N
    Bordigoni, P
    Babin-Boilletot, A
    Bensaid, P
    Manel, AM
    Vilmer, E
    Thuret, I
    Blanche, S
    Gluckman, E
    Fischer, A
    Mechinaud, F
    Joly, B
    Lamy, T
    Hermine, O
    Cassinat, B
    Bellanné-Chantelot, C
    Chomienne, C
    HAEMATOLOGICA, 2005, 90 (01) : 45 - 53